ææ°ã® Novo Nordisk A/S ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
8æ6æ¥ã®Novo Nordisk A/S (NVO) çµå€ã¯3.11%äžæïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
8æ4æ¥ã®Amgen Inc (AMGN) çµå€ã¯3.03%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
7æ31æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯8.75%äžèœïŒå®å šãªåæ
7æ15æ¥ã®Novo Nordisk A/S (NVO) çµå€ã¯3.02%äžæïŒå®å šãªåæ
6æ22æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯6.81%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
6æ8æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯3.46%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
6æ1æ¥ã®Novo Nordisk A/S (NVO) çµå€ã¯3.41%äžèœïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
5æ15æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯3.09%äžèœïŒå®å šãªåæ
5æ11æ¥ã®Eli Lilly and Co (LLY) å€åãã¯4.36%äžæïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
5æ4æ¥ã®Axsome Therapeutics Inc (AXSM) å€åãã¯10.20%äžæïŒå€åãã®èåŸã«ããäºå®